- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
11
11 companies
WuXi XDC Cayman
Market Cap: HK$70.6b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$58.90
7D
11.2%
1Y
28.9%
XtalPi Holdings
Market Cap: HK$39.9b
An investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally.
2228
HK$9.60
7D
1.1%
1Y
52.6%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$36.8b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$58.45
7D
12.8%
1Y
289.7%
RemeGen
Market Cap: HK$64.8b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$94.15
7D
1.0%
1Y
302.4%
CanSino Biologics
Market Cap: HK$12.5b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.28
7D
-2.7%
1Y
-5.3%
Consun Pharmaceutical Group
Market Cap: HK$13.9b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$17.39
7D
6.9%
1Y
94.3%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.67
7D
0.8%
1Y
46.7%
Innovent Biologics
Market Cap: HK$137.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$85.50
7D
5.5%
1Y
85.1%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.5b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.71
7D
-7.1%
1Y
-11.8%
Luye Pharma Group
Market Cap: HK$9.2b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.41
7D
2.1%
1Y
-2.8%
China Medical System Holdings
Market Cap: HK$31.2b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$13.29
7D
-1.5%
1Y
68.0%